Return to homepagePandemic Pact

A randomized controlled trial of single-dose oral ivermectin in patients with COVID19 infection

Grant number: CVD/2020/001105

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    SERB India

  • Principal Investigator

    Dr. Anant Mohan

  • Research Location

    India

  • Lead Research Institution

    All India Institute of Medical Sciences

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Drug repurposing against key COVID-19 targets

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.